This document explains the main differences between two sets of performance metrics:



Similar documents
National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP)

Attributing the costs of health and social care Research & Development (AcoRD)

Summary of the role and operation of NHS Research Management Offices in England

An introduction to Research Management and Governance (RM&G) in the NHS

Attributing the costs of health and social care Research & Development (AcoRD)

Q1. Why have you revised the guidance on attributing Research Costs, Support Costs and Treatments Cost in the NHS?

Document Title: Research Database Application (ReDA)

Trust/Host Site Approval. Presented by: Anika Kadchha Research Governance Officer

The Health Research Authority. Janet Wisely. April 2015

CLINICAL RESEARCH NETWORK

CRN: South London Funding Model

Document Title: Trust Approval and Research Governance

Research funding applications involving Cardiff & Vale UHB. Emma Lewis R&D Coordinator. Cardiff and Vale UHB Bwrdd lechyd Prifysgol Caerdydd a r Fro

NIHR Guideline B01 Research & Development Operational Capability Statement V Updated March 20145

INCOME DISTRIBUTION FROM NIHR ADOPTED INDUSTRY SPONSORED STUDIES

Archiving of Research Documentation

Study-wide considerations: identifies the areas of the criterion the lead reviewer should consider when conducting the review

NIHR Clinical Research Network Learning Management System (LMS)

gsop Vendor Assessment SOP page 1 of 10

University Hospital Southampton NHS Foundation Trust

NORWICH CLINICAL TRIALS UNIT OVERVIEW

OxB01 v1.00. R&D Operational Capability Statement

Proportionate Review (PR) IRAS Application & Documents. Authorisations & Signatures. Contact CBS Team

Document Title: Project Management of Papworth Sponsored Studies

Dorset Research Consortium. Research Governance: A handbook for Researchers in Dorset

NIHR Research Design Service London Dr Peter Lovell Deputy Director

Adopting Site Quality Management to Optimize Risk-Based Monitoring

Appendix 3 INDIVIDUAL PATIENT DRUG TREATMENT. POLICY AND PROCESS FOR DECISION MAKING September 2007

RESEARCH AND DEVELOPMENT GAINING NHS RESEARCH PERMISSION FROM CARDIFF AND VALE UHB - GUIDANCE FOR RESEARCHERS. Research Governance Group

RESEARCH TRAINING & CAREER DEVELOPMENT

STANDARD OPERATING PROCEDURE. Risk Assessment of STH sponsored CTIMPs

Trial Delivery SOP 05 Trial Archiving

The Royal Wolverhampton NHS Trust

Policy Flowchart. Policy Title: Research Governance, Conduct and Management Policy. Reference and Version No: IG6 Version 5

Research Study Close-down and Archiving Procedures

EHR4CR ENABLING PROACTIVE RESEARCH

Marie-Claire Rickard, GCP & Governance Manager Rachel Fay, GCP & Governance Manager Elizabeth Clough, R&D Operations Manager

COMPLAINTS FROM RESEARCH SUBJECTS ABOUT UCL SPONSORED STUDIES AND TRIALS

Standard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL

Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009

Principles for Responsible Clinical Trial Data Sharing

Executive Summary and Recommendations: National Audit of Learning Disabilities Feasibility Study

ECONOMIC FOOTPRINT OF CTs IN BELGIUM STRATEGIC PLAN TO PROMOTE CTs

Hyperion Asset Management Limited Brokerage Allocations (Soft Dollar Dealing) and Adviser Commission Policy

A Guide to Efficient Trial Management. Trials Managers Network

Canadian Cancer Clinical Trials Network Request for Application 2015 Network Affiliated Cancer Centre. Submission Guidelines

CENTRAL MANCHESTER UNIVERSITY HOSPITALS NHS FOUNDATION TRUST

Recognition of Prior Learning (RPL) Kit. BSB50607 Diploma of Human Resources Management

Medicines for Human Use (Clinical Trials Regulations) Informed consent in clinical trials

The new EU Clinical Trials Regulation How NHS research and patients will benefit

Wales Patient Access Scheme: Process Guidance

North East London Cancer Research Network. Annual Report

New Beginnings. Nonprofit Incubator Guidelines

Frequently Asked Questions Special Handling Labor Certification

DATA MANAGEMENT IN CLINICAL TRIALS: GUIDELINES FOR RESEARCHERS

Research & Development Guidance for Students

TransCelerate's Role in Transforming Pharmaceutical Trials Presentation to PCORNet

Introduction The Role of Pharmacy Within a NHS Trust Pharmacy Staff Pharmacy Facilities Pharmacy and Resources 6

Priority Program Translational Oncology Applicants' Guidelines

Improving Emergency Care in England

The anatomy of a grant proposal

Five Simple Steps to Increase Supplier Adoption of einvoicing Jeff White

Competency Framework for Non-Clinical Research Staff

CONTROLLED DOCUMENT- DO NOT COPY STANDARD OPERATING PROCEDURE. STH Investigator

SUMMARY PLAN DESCRIPTION

An information platform that delivers clinical studies better, faster, safer and more cost effectively

TRIAL MASTER FILE- SPONSORED

Transcription:

Document Version 2.0 Date November 2013 The (70 day benchmark) and the NIHR Clinical Research Network High Level Objectives: a description of purpose, definition and differences Introduction This document explains the main differences between two sets of performance metrics: 1. The exercise, relating to the 70-day benchmark and delivery of trials to time and to target by individual providers of NHS Services which have entered into a contract with NIHR since Autumn 2011; and, 2. The NIHR Clinical Research Network (CRN) High Level Objectives (HLOs) which relate to the initiation and delivery of clinical research studies included on the NIHR CRN Portfolio. What are the metrics and why have they been introduced? The Government wishes to see a dramatic and sustained improvement in the performance of providers of NHS services in initiating and delivering clinical research. The Performance in Initiating and metrics, announced in the Government s Plan for Growth 1, require providers of NHS services to submit performance data on a 70-day benchmark to recruit first patients into clinical trials. They also include the Performance in Delivery exercise, which measures delivery of commercial contract trials to time and target so the incentive for trusts to set up studies quickly is balanced with an incentive that trusts will not do so without proper feasibility and then fail to deliver. Submission by providers of NHS services 2 of data on their performance against these benchmarks has been a condition of all new NIHR contracts since autumn 2011. The exercise encourage accountability for performance in the initiation and delivery of clinical trials within individual providers of NHS services. What are the? The are the CRN s agreed performance objectives for CRN activity. The High Level Objectives include targets to increase the proportion of studies in the NIHR CRN Portfolio that deliver to their planned recruitment time and target, to reduce the time taken to achieve NHS permission through the Coordinated System for gaining NHS Permission (CSP), and to reduce the time taken to recruit first participants into NIHR CRN Portfolio studies. They were introduced in April 2010. The CRN High Level Objectives encourage improved performance across whole clinical research studies, which are likely to be taking place across several providers of NHS services. 1 http://cdn.hm-treasury.gov.uk/2011budget_growth.pdf 2 http://www.nihr.ac.uk/systems/pages/clinicaltrialperformance.aspx NIHR Metrics Comparison v2.0 November 2013 Page 1 of 5

Do the exercise and the share the same aims? Yes, both sets of performance metrics share the same overall aims, which are to increase the number of patients able to participate in research and enhance the nation s attractiveness as a host for research. The two sets of metrics complement each other: the NIHR Performance in Initiating and encourages accountability within individual providers of NHS services, while the CRN High Level Objectives encourage improved performance across whole studies. However, there are several key differences between them which are outlined below. What are the main differences between the and the CRN High Level Objectives? The focus of the is within individual providers of NHS services. The focus of the is on the performance of entire clinical research studies included on the NIHR CRN Portfolio. Further important differences between the two sets of metrics: 1) Inclusive research 2) Two separate data collections Data is collected for clinical trials only 3 ; as described in the first four definitions of question 2 of the IRAS Filter, regardless of funder or inclusion in the NIHR Portfolio. Apply to all studies that are processed through the NIHR CRN systems and apply to all types of research that are eligible for CRN support and included in the NIHR Portfolio, not just Clinical Trials of an Investigational Medicinal Products (CTIMPs). Submitted directly from NHS Provider to the NIHR Central Commissioning Facility (CCF) on a quarterly basis, via the Clinical Trials Performance Submission Platform. Performance data on the HLOs are collected on an ongoing basis via the NIHR CRN information systems. 3) Comparing and contrasting the Delivering Clinical Research and 40 and 30 day High Level Objective Targets: Measurements start points, clock-stopping and end points Measurements a) The Performance in Initiating (70-day) benchmark is a single measure taken from the date of receipt of Valid Research Application 3 to the date of First Patient Recruitment. Measures performance at an individual provider of NHS Services. Data collection does include time taken to gain NHS Permission, but this does not constitute a separate benchmark. b) Measuring performance at individual providers of NHS services. 3 http://www.ccf.nihr.ac.uk/documents/performance%20guidelines%20public.pdf NIHR Metrics Comparison v2.0 November 2013 Page 2 of 5

Start-points a) Include two separate targets: firstly, a median target of 40 days for the time taken for an NIHR CRN study to achieve NHS Permission at all sites; secondly, a target of 30 days for time taken to recruit a first patient in to an NIHR CRN study once Permission has been issued. b) Measuring performance across a whole study. For CSP studies, the start point metric is the date of receipt of Valid Research Application (Site Specific Information and associated documents) for local review. For non-csp studies, the start point is the receipt of an entire Valid Research Application package, as described on the associated IRAS Checklist. The start point of the HLO4 metric, relating to the median time taken across all sites to achieve NHS Permission though CSP is the receipt of the Valid R&D Submission. The CRN s High Level Objective 4, reduce the time taken to achieve NHS permission through CSP for NIHR studies, captures all applications received through CSP, which also includes BRC, BRU and CLAHRC studies. Eligibility of research studies for inclusion on the NIHR CRN portfolio and thus access to CSP are defined at http://www.crncc.nihr.ac.uk/about_us/processes/portfolio/p_eligibility Clock-stopping End-points There is no clock-stopping for NIHR Performance in Initiating and. The NIHR understands that, especially at the beginning of the exercise, there will be a number of reasons why the Performance in Initiating (70-day) benchmark is not met. Providers of NHS services are therefore asked to provide explanation as to the nature of delays to initiation of clinical trials that do not meet the benchmark. The include clockstops, as these objectives aim to exclude factors that are completely outside the CRN s remit; for example the time from NHS permission to first Network Site Initiation Visit for commercial contract studies. For the 70-day benchmark, the end point is the date of First Patient Recruitment. The date of First Patient Recruitment means the date that the first patient (or legal representative) provided informed consent, as recorded on the associated informed consent form. The High Level Objective relating to the recruitment of the first patient is measuring performance across a whole study, so the end point of the metric is the date that the first patient is recruited to the whole study, across all sites. The date of first patient recruitment means the date that the first patient consented to the study. 4) for Delivering Clinical Research and Recruitment to Time and Target for The initial focus is on commercial contract clinical trials. The NIHR CCF collects performance data from providers of NHS services on recruitment to time and target for every NIHR Metrics Comparison v2.0 November 2013 Page 3 of 5

5) Excluded research commercial contract clinical trial which the provider has hosted within the previous 12 months. The NIHR CRN collects performance data on recruitment to time and target for all commercial contract and noncommercial studies in the NIHR CRN Portfolio which started on or after April 1 st 2010 (HLO2). Data is not collected for any studies other than clinical trials, as described in the first four definitions of question 2 of the IRAS Filter. Certain studies are excluded from the measurement, with the aim of eliminating factors completely outside the control of the NIHR CRN. For example, commercial contract studies which are terminated by the sponsor for safety issues. Can data collected also be used for reporting to the NIHR CCF on the Delivering Clinical Research? The and the NIHR CRN High Level Objectives measure separate aspects of clinical research, however some of the data points may overlap. It is important to note that the only apply to Portfolio studies which are processed through CSP and therefore the data collected for these measures is not comprehensive enough to provide the full dataset required for the NIHR Performance in Initiating and data which covers both Portfolio and Non-Portfolio studies. When collating returns to CCF, providers of NHS services can use relevant NIHR CRN High Level Objective data points for those studies processed through CSP to contribute to the data submission for calculation of the NIHR Performance in Initiating (70-day) benchmark: for example, the time to complete local processes and issue permission. Dates for the first patient recruited at individual sites for studies on the NIHR CRN Portfolio are not currently collected in national NIHR CRN information systems to enable use by providers of NHS services. This is because the Delivering Clinical Research metrics are currently collected by CCF on an individual provider of NHS services basis, whereas the CRN HLOs are recorded in CRN information systems on a whole study basis. Where are the Data and the NIHR CRN High level objectives published? The data is published by each provider of NHS services with a relevant NIHR Contract on their own website. There is a minimal data set which must be published at the end of each quarter. The latest list of providers of NHS services can be accessed via the NIHR website at: http://www.nihr.ac.uk/systems/pages/clinicaltrialperformance.aspx The CRN High Level Objectives are published in quarterly performance reports written by the Clinical Research Network and can be accessed via the Coordinating Centre Website at: http://www.crncc.nihr.ac.uk/about_us/performance_objectives.htm NIHR Metrics Comparison v2.0 November 2013 Page 4 of 5

Figure 1: Differences between the NIHR Performance in Initiating (70-day) benchmark and the CRN High Level Objectives. 00 Performance in Initiating (70-day) benchmark Receipt of Valid Research Application NHS Permission from providers of NHS services recruited at site Trial recruitment closes NIHR CRN High Level Objectives Day 0 HLO #4: 40 days (Median) Receipt of valid R&D submission for study Day 0 NHS Permission at all sites (median) Day 40 HLO #5: 30 days First Network site NHS Permission or Site Initiation Visit Day 40 recruited into study NIHR Metrics Comparison v2.0 November 2013 Page 5 of 5 HLO #2: Study specific recruitment target in planned recruitment period recruited into study Trial recruitment closes time and target met? Day X